Vancouver, BC, July 11, 2025 – TheNewswire - GAMMA RESOURCES LTD. (TSX.V:GAMA, FSE:6GC, OTC:MLLOF) (“Gamma” or the “Company”) is pleased to announce that it has appointed Mr. Chad McMillan to serve as a Strategic Advisor to the Company.Mr. McMillan is a dynamic senior executive with over twenty years of experience in and around the capital markets building, running, and helping finance public companies.  He is well versed in executive management, corporate finance, mergers and acquisitions, corporate commun ...

Core Insights - Dave Inc.'s ExtraCash service is crucial for the underbanked, representing 14.2% of U.S. households in 2023 [1][2] - The underbanked prefer neobanks due to limited access to affordable credit and high fees from traditional banks [2] - ExtraCash provides interest-free cash advances up to $500 without traditional credit checks, utilizing alternative data underwriting [3] - The new fee structure for ExtraCash, with a 5% fee capped at $15, enhances transparency and affordability for users [4] - Mobile banking is on the rise, with over 79% of the population expected to use online banking by 2029, positioning Dave's mobile-first platform favorably [5] - ExtraCash helps users avoid costly traditional banking fees, promoting financial resilience and inclusion [6] Financial Performance - DAVE's stock has increased by 657.6% over the past year, outperforming the industry average of 45.8% and competitors CoreCard and Qifu Technology [7] - DAVE trades at a forward price-to-earnings ratio of 25.69, higher than the industry average and Qifu Technology's 23.15 [11] - The Zacks Consensus Estimate for DAVE's earnings in 2025 is $8.74 per share, reflecting a 66.8% increase from the previous year [14]

Core Insights - Aeva Technologies (AEVA) has experienced a dramatic stock price increase of approximately 1,200%, rising from $2.50 in September to $30, with a peak of $38.80 in June, adding about $1.5 billion to its market value [1][6] - The surge is attributed to increased product sales, a $50 million investment from a strategic partner, and more orders from industrial clients, but questions remain about the sustainability of this growth [1][6] - The LiDAR technology market is still developing, and while AEVA's FMCW-based sensors are unique, competition from manufacturers developing in-house LiDAR systems poses a risk to AEVA's market share [1][2] Financial Performance - Aeva Technologies' stock has surged nearly 700% in the first half of 2025 [5] - The company's current valuation stands at $1.7 billion, which raises concerns when compared to competitors like Ouster (OUST), which reported $32.6 million in revenues in the first quarter of 2025, nearly ten times AEVA's revenue [2][6] - AEVA's forward price-to-sales ratio is 53, significantly higher than the industry average, indicating potential overvaluation [7] Competitive Landscape - Ouster's healthy profit margin of 41% and expected revenue growth of around 30% this year highlight the competitive challenges AEVA faces [2] - The valuation of AEVA at $1.7 billion compared to Ouster's $1.2 billion suggests that AEVA's stock price may be pricing in future growth that has not yet materialized [2]

Hello everyone. This is Tana from Llama Index and I want to walk you through the Llama Cloud MCP server that we created which is completely open sourced and this is the one that we created in Python uh which allows you to use Llama Cloud indexes and extraction agents as tools within any MCP client. And today I'm going to show you how um you can set it up to use with cloud desktop for example.So to start with, let's have a look at my Llama Cloud account. And you'll see that for example here I have two indexe ...

Gateways to be Deployed Across Virginia Schools Entrances to Further Secure Learning Environments.TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Mecklenburg County Public Schools, located in Boydton, Virginia, to enhance school security and ensure student, staff, and visitor safety. After extensive analysis of the industry, Mecklenburg County ...

Key Takeaways Posco plans a U.S. lithium pilot plant with Anson Resources to test its Direct Lithium Extraction technology. PKX targets reducing dependence on Chinese suppliers to comply with new U.S. import restrictions. PKX aims to commercialize its DLE technology across North America's untapped lithium brine resources.Posco Holdings (PKX) has announced plans to develop a trial lithium processing plant in the United States in collaboration with Australia's Anson Resources. This is in sync with the compa ...

Core Viewpoint - Christina Lake Cannabis Corp. (CLC) announced a delay in filing its annual financial statements for the fiscal year ended February 28, 2025, due to extended audit processes and resource limitations [1][2]. Group 1: Filing Delay - CLC will not file its annual financial statements by the prescribed deadline of June 30, 2025, due to the audit taking longer than expected [1][2]. - The delay is attributed to the high level of testing required and limited staff availability, particularly concerning inventory and biological assets [2]. - The increased production levels and new product lines following the Midway acquisition have complicated the costing and inventory allocation processes [2]. Group 2: Auditor and Compliance - CLC is collaborating with its auditor DMCL LLP to ensure timely submission of the annual filings, with an expected filing date no later than July 14, 2025 [3]. - The company has applied for a management cease trade order (MCTO) to prevent the CEO and CFO from trading in CLC securities until the filings are completed [3]. - The MCTO application is subject to the risk of not being successful, which could lead to further trading restrictions [3][4]. Group 3: Company Operations - CLC is a licensed cannabis producer with a focus on high-quality extracts and distillates, operating on a 32-acre property with over 950,000 square feet of outdoor grow space [5]. - The company has secured necessary licenses from Health Canada for cultivation, processing, and research and development [5]. - CLC's production strategy includes proprietary strains developed for outdoor cultivation to enhance extraction quality [5].

Wall Street is set to wrap up one of the strongest monthly advances so far in 2025, fueled by optimism surrounding global trade and easing fears over tariffs. The S&P 500 and the Nasdaq Composite Index closed at an all-time high Friday, another milestone in the stock market’s remarkable recovery from a springtime plunge caused by fears that the Trump administration’s trade policies could harm the economy.With just a day left to close the month, the S&P 500 has climbed 4.4%, and the tech-heavy Nasdaq rose ne ...

Hey there, Clia here from Lama Index and today we're going to see how a syllabus extraction agent uh can work. So this agent is basically designed to extract information from a university course syllabus and to give you some summary information about the syllable the syllabus. So let's uh start with this syllabus here. Let's submit it uh so that we can see basically the agent at work.And first is the syllabus extractor tool that use that uses slama extract from llama cloud and basically extracts the informa ...

Core Insights - A new study published by Tilray Medical focuses on the bioavailability of different cannabinoid formulations, specifically comparing Tilray's THC:CBD extract and nabiximols [1][4] Group 1: Study Overview - The study assessed pharmacokinetic parameters and relative bioavailability of two formulations: Tilray THC:CBD extract (10 mg/mL each of THC and CBD) and nabiximols (total dose of 10.8 mg THC and 10 mg CBD) [2] - Conducted with twelve healthy volunteers, the study revealed that the Cmax for THC and CBD was significantly higher for the Tilray extract compared to nabiximols [3] Group 2: Key Findings - The study found that THC and CBD were undetectable 24 hours post-dose, and 11-OH-THC was markedly reduced from its peak [3] - No serious adverse events were reported during the study, indicating a favorable safety profile for the Tilray formulation [3] Group 3: Implications and Future Directions - The findings suggest that the oral administration of Tilray's THC:CBD extract may achieve higher cannabinoid concentrations more quickly than nabiximols, which could have significant implications for therapeutic use [4] - Tilray's Medical Director emphasized the importance of understanding cannabinoid pharmacokinetics to enhance therapeutic outcomes [5]